Simplifying First Trimester Medical Abortion Follow-up

NCT ID: NCT03014193

Last Updated: 2017-11-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-31

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the usability of the multilevel pregnancy test among women undergoing medical abortion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medical Abortion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Semiquantitative Multi-Level Pregnancy Test

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have a first trimester pregnancy with a gestational age of ≤63 days;
* Desire medical abortion with mifepristone and misoprostol and be medically eligible for that treatment, according to clinic protocol;
* Be able to read and understand the local language or Russian;
* Have access to a telephone;
* Agree to follow all study procedures;
* Have no contraindication to participation in the study, in the judgment of the site investigator or designee.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gynuity Health Projects

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gyumri Maternity Hospital

Gyumri, , Armenia

Site Status

Republican Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology

Yerevan, , Armenia

Site Status

Batumi International Hospital

Batumi, , Georgia

Site Status

David Gagua Clinic

Tbilisi, , Georgia

Site Status

City Policlinic #17

Almaty, , Kazakhstan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Armenia Georgia Kazakhstan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6009

Identifier Type: -

Identifier Source: org_study_id